HOE901 Insulin Analogue
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HOE901 Insulin Analogue, covering 2007-10-01 to 2007-10-01. Get the full timeline:
Most recent: Clinical Trial Update: 32 Week, Open, Randomized, 2 Way Cross Over Multicentre Trial to Compare Safety & Efficacy of Combination of HOE901 Insulin Analogue Once Daily at Bedtime + Lispro Insulin Before Meals vs NPH Insulin (Twice a Day) + Regular in Type 1 Diabetes Mellitus [Phase 3]